Boundless Bio, Inc. BOLD NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

Il y a eu 50 transactions d'initiés récentes enregistrées pour Boundless Bio, Inc. (BOLD), dont 20 achats et 28 ventes. Le total des achats d'initiés s'élève à $2.73M et le total des ventes d'initiés à $16.57M.

Les initiés notables ayant une activité récente comprennent Hinkle David A, Hornby Zachary, Hassig Christian. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — BOLD

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-01-23	Hinkle David A	See Remarks	Attribution de RSU	140,000	$1.26	$176.4K	140,000
2026-01-23	Hornby Zachary	President & CEO	Attribution de RSU	600,000	$1.26	$756K	600,000
2026-01-23	Hassig Christian	Chief Scientific Officer	Attribution de RSU	230,000	$1.26	$289.8K	230,000
2026-01-23	Oien Jessica	See Remarks	Attribution de RSU	220,000	$1.26	$277.2K	220,000
2026-01-23	Doebele Robert	Chief Medical Officer	Attribution de RSU	230,000	$1.26	$289.8K	230,000
2025-06-23	Lim Jonathan E	Director	Attribution de RSU	24,000	$1.03	$24.72K	24,000
2025-06-23	Lew Jennifer	Director	Attribution de RSU	16,000	$1.03	$16.48K	16,000
2025-06-23	Burow Kristina	10 Percent Owner	Attribution de RSU	16,000	$1.03	$16.48K	16,000
2025-06-23	Whiting Nancy	Director	Attribution de RSU	16,000	$1.03	$16.48K	16,000
2025-06-23	Christensen James	Director	Attribution de RSU	16,000	$1.03	$16.48K	16,000
2025-06-23	Brennan Christine	Director	Attribution de RSU	16,000	$1.03	$16.48K	16,000
2020-01-15	Patterson Matthew R	Chief Executive Officer	Restitution d'Actions	177,450	$24.74	$4.39M	-
2020-01-15	Soloway Thomas P	Executive Vice President, CFO	Restitution d'Actions	65,000	$24.74	$1.61M	-
2020-01-15	Goldberg Mark Alan	Director	Restitution d'Actions	16,200	$24.74	$400.79K	-
2020-01-15	Holles Natalie C.	President and COO	Restitution d'Actions	50,105	$24.74	$1.24M	-
2020-01-15	Conner Edward R.	SVP, Chief Medical Officer	Restitution d'Actions	90,000	$36.08	$3.25M	-
2020-01-08	Patterson Matthew R	Chief Executive Officer	Exercice d'Options (Vente)	64,751	$0.78	$50.51K	-
2020-01-08	Soloway Thomas P	Executive Vice President, CFO	Exercice d'Options (Vente)	144,669	$2.76	$400K	3,829
2019-12-26	Patterson Matthew R	Chief Executive Officer	Don (Donné)	12,500	-	-	98,920
2019-12-12	Soloway Thomas P	Executive Vice President, CFO	Retenue Fiscale RSU	8,681	$59.37	$515.39K	12,633
2019-12-12	Holles Natalie C.	President and COO	Exercice d'Options (Vente)	5,715	$9.50	$54.29K	548
2019-12-12	Conner Edward R.	SVP, Chief Medical Officer	Retenue Fiscale RSU	5,416	$59.37	$321.55K	24,584
2019-12-05	Patterson Matthew R	Chief Executive Officer	Retenue Fiscale RSU	1,974	$59.21	$116.88K	111,420
2019-12-05	Soloway Thomas P	Executive Vice President, CFO	Retenue Fiscale RSU	505	$59.21	$29.9K	21,314
2019-12-05	Holles Natalie C.	President and COO	Retenue Fiscale RSU	505	$59.21	$29.9K	54,704
2019-11-08	Patterson Matthew R	Chief Executive Officer	Vente Informative	14,426	$30.00	$432.78K	113,394
2019-09-05	Patterson Matthew R	Chief Executive Officer	Retenue Fiscale RSU	1,974	$31.02	$61.23K	113,394
2019-09-05	Soloway Thomas P	Executive Vice President, CFO	Retenue Fiscale RSU	505	$31.02	$15.67K	21,819
2019-09-05	Holles Natalie C.	President and COO	Retenue Fiscale RSU	505	$31.02	$15.67K	55,209
2019-08-12	Patterson Matthew R	Chief Executive Officer	Vente Informative	1,000	$34.53	$34.53K	115,368
2019-07-15	Conner Edward R.	Officer	Inconnu	-	-	-	-
2019-07-15	Conner Edward R.	SVP, Chief Medical Officer	Attribution de RSU	30,000	-	-	30,000
2019-06-05	Patterson Matthew R	Chief Executive Officer	Retenue Fiscale RSU	3,332	$37.31	$124.32K	115,368
2019-06-05	Soloway Thomas P	Executive Vice President, CFO	Retenue Fiscale RSU	1,009	$37.31	$37.65K	22,324
2019-06-05	Holles Natalie C.	President and COO	Retenue Fiscale RSU	1,009	$37.31	$37.65K	55,714
2019-02-25	Patterson Matthew R	Chief Executive Officer	Exercice d'Options (Vente)	17,000	$0.78	$13.26K	64,751
2019-02-06	Patterson Matthew R	Chief Executive Officer	Attribution de RSU	63,700	-	-	118,700
2019-02-06	Soloway Thomas P	Executive Vice President, CFO	Attribution de RSU	23,333	-	-	23,333
2019-02-06	Goldberg Mark Alan	Director	Attribution de RSU	16,200	$24.74	$400.79K	16,200
2019-02-06	Holles Natalie C.	President and COO	Attribution de RSU	23,333	-	-	56,723
2019-01-24	Holles Natalie C.	President and COO	Exercice d'Options	8,300	$2.76	$22.95K	33,390
2018-12-06	Patterson Matthew R	Chief Executive Officer	Exercice d'Options (Vente)	40,000	$0.78	$31.2K	31,702
2018-10-01	Patterson Matthew R	Chief Executive Officer	Vente Informative	2,144	$39.14	$83.91K	15,000
2018-09-24	Patterson Matthew R	Chief Executive Officer	Exercice d'Options	15,000	$0.78	$11.7K	15,000
2018-09-18	Patterson Matthew R	Chief Executive Officer	Vente Informative	12,952	$40.00	$518.08K	-
2018-07-05	Patterson Matthew R	Chief Executive Officer	Vente Informative	23,147	$40.04	$926.85K	-
2018-07-03	Patterson Matthew R	Chief Executive Officer	Vente Informative	26,901	$40.05	$1.08M	-
2018-07-02	Patterson Matthew R	Chief Executive Officer	Vente Informative	19,599	$38.33	$751.19K	-
2018-06-08	Goldberg Mark Alan	Director	Attribution de RSU	10,000	$38.65	$386.5K	10,000
2018-06-01	Holles Natalie C.	President and COO	Exercice d'Options	5,090	$2.76	$14.07K	25,090

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration